Illumina Financial Statements (ILMN) |
||||||||||
Illuminasmart-lab.ru | % | 2021 | 2022 | 2022 | 2023 | LTM ? | ||||
---|---|---|---|---|---|---|---|---|---|---|
Report date | 18.02.2022 | 03.07.2022 | 01.01.2023 | 17.02.2023 | 16.02.2024 | 03.05.2024 | ||||
Currency | USD | USD | USD | USD | USD | USD | ||||
Financial report URL | ||||||||||
Revenue, bln rub | ? | 4 526 | 4 584 | 4 584 | 4 504 | 4 439 | ||||
Operating Income, bln rub | -123.0 | -4 179 | -4 179 | -70.0 | -1 086 | |||||
EBITDA, bln rub | ? | -123.0 | -4 336 | 4 887 | 362.0 | 661.0 | ||||
Net profit, bln rub | ? | 762.0 | -4 404 | -4 404 | -1 161 | -1 232 | ||||
OCF, bln rub | ? | 545.0 | 392.0 | 392.0 | 477.0 | 663.0 | ||||
CAPEX, bln rub | ? | 208.0 | 286.0 | 466.0 | 196.0 | 183.0 | ||||
FCF, bln rub | ? | 337.0 | 106.0 | -74.0 | 281.0 | 480.0 | ||||
Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
OPEX, bln rub | 3 277 | 5 539 | 2 618 | 2 820 | 2 954 | |||||
Cost of production, bln rub | 1 372 | 1 612 | 1 612 | 1 754 | 1 739 | |||||
R&D, bln rub | 1 185 | 1 321 | 1 321 | 1 330 | 1 324 | |||||
Interest expenses, bln rub | 61.0 | 0.000 | 26.0 | 77.0 | 55.0 | |||||
Assets, bln rub | 15 217 | 15 448 | 12 252 | 12 252 | 10 111 | 10 040 | ||||
Net Assets, bln rub | ? | 10 740 | 10 444 | 6 599 | 6 599 | 5 745 | 7 866 | |||
Debt, bln rub | 2 469 | 1 521 | 1 492 | 3 479 | 2 262 | 700.0 | ||||
Cash, bln rub | 1 339 | 1 327 | 26.0 | 2 037 | 1 054 | 1 108 | ||||
Net debt, bln rub | 1 130 | 194.0 | 1 466 | 1 442 | 1 208 | -408.0 | ||||
Ordinary share price, rub | 380.4 | 191.0 | 202.2 | 202.2 | 139.2 | 112.8 | ||||
Number of ordinary shares, mln | 150.0 | 157.0 | 157.0 | 158.0 | 159.0 | |||||
Market cap, bln rub | 57 066 | 0 | 31 745 | 31 745 | 22 000 | 17 929 | ||||
EV, bln rub | ? | 58 196 | 194 | 33 211 | 33 187 | 23 208 | 17 521 | |||
Book value, bln rub | 377 | 84 | 75 | 75 | 207 | 2 381 | ||||
EPS, rub | ? | 5.08 | -28.1 | -28.1 | -7.35 | -7.75 | ||||
FCF/share, rub | 2.25 | 0.68 | -0.47 | 1.78 | 3.02 | |||||
BV/share, rub | 2.51 | 0.48 | 0.48 | 1.31 | 15.0 | |||||
EBITDA margin, % | ? | -2.72% | -94.6% | 106.6% | 8.04% | 14.9% | ||||
Net margin, % | ? | 16.8% | -96.1% | -96.1% | -25.8% | -27.8% | ||||
FCF yield, % | ? | 0.59% | 0.00% | 0.33% | -0.23% | 1.28% | 2.68% | |||
ROE, % | ? | 7.09% | 0.00% | -66.7% | -66.7% | -20.2% | -15.7% | |||
ROA, % | ? | 5.01% | 0.00% | -35.9% | -35.9% | -11.5% | -12.3% | |||
P/E | ? | 74.9 | -7.21 | -7.21 | -18.9 | -14.6 | ||||
P/FCF | 169.3 | 299.5 | -429.0 | 78.3 | 37.4 | |||||
P/S | ? | 12.6 | 6.93 | 6.93 | 4.88 | 4.04 | ||||
P/BV | ? | 151.4 | 0.00 | 423.3 | 423.3 | 106.3 | 7.53 | |||
EV/EBITDA | ? | -473.1 | -7.66 | 6.79 | 64.1 | 26.5 | ||||
Debt/EBITDA | -9.19 | -0.34 | 0.30 | 3.34 | -0.62 | |||||
R&D/CAPEX, % | 569.7% | 461.9% | 283.5% | 678.6% | 723.5% | |||||
CAPEX/Revenue, % | 4.60% | 6.24% | 10.2% | 4.35% | 4.12% | |||||
Illumina shareholders |